Vitrolife´s CEO sells a portion of his shareholding

Rhea-AI Summary

On December 7, 2021, Vitrolife's CEO Thomas Axelsson sold 38,300 shares for approximately SEK 18.7 million. This sale leaves him with 13,000 shares remaining. Axelsson cited the positive development of the share price since his acquisition in 2012 as a reason to realize part of his profit for personal financial needs. The transaction will be reported to the Swedish Financial Supervisory Authority per regulations. This announcement is mandated under the EU Market Abuse Regulation, with details provided at 10:50 am CET.

Positive

• CEO Thomas Axelsson realizes a profit after a positive share performance since 2012.

Negative

• Selling a large portion (38,300 shares) may signal to investors about potential concerns or personal liquidity needs.

GÖTEBORG, Sweden, Dec. 7, 2021 /PRNewswire/ -- Vitrolife's CEO Thomas Axelsson has today sold 38,300 shares worth SEK 18.7 million. The remaining number of shares amounts to 13,000 shares.

"The Vitrolife share has developed very positively since I acquired the shares in 2012 and I therefore choose to realize part of the profit for private financial reasons," says Thomas Axelsson, CEO of Vitrolife AB. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.

Gothenburg, December 7, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO

CONTACT:

Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10.50 am CET on December 7, 2021.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/vitrolife-s-ceo-sells-a-portion-of-his-shareholding,c3467130

The following files are available for download:

https://mb.cision.com/Main/1031/3467130/1506430.pdf

Försäljning aktier

 

View original content:https://www.prnewswire.com/news-releases/vitrolifes-ceo-sells-a-portion-of-his-shareholding-301438740.html

SOURCE Vitrolife AB (publ)

FAQ

What shares did Vitrolife's CEO sell on December 7, 2021?

Vitrolife's CEO Thomas Axelsson sold 38,300 shares.

How much did Thomas Axelsson earn from the share sale?

He earned approximately SEK 18.7 million from the sale.

How many shares does Thomas Axelsson have left after the sale?

He retains 13,000 shares after the sale.

What was the reason for the share sale by Vitrolife's CEO?

The CEO sold the shares to realize part of his profit for personal financial reasons.

Which regulatory body will report the transaction of Thomas Axelsson's share sale?

The transaction will be reported to the Swedish Financial Supervisory Authority.